Skip to main content
. Author manuscript; available in PMC: 2016 Nov 8.
Published in final edited form as: Osteoporos Int. 2010 Aug 4;22(3):789–796. doi: 10.1007/s00198-010-1359-2

Fig. 1.

Fig. 1

Percentage of women with a new fragility fracture on no medical therapy for osteoporosis (solid line), or on treatment with a bisphosphonate (medium-sized dotted line), or on hormone therapy (small-sized dotted line)